Gossamer Bio (GOSS) Metrics: History & Chart

Gossamer Bio, Inc.(GOSS)

Biotechnology · San Diego, CA

$10.64-0.01 (-0.09%)

Delayed quote: Oct 6, 2026, 12:45 PM EDT

About Gossamer Bio, Inc.

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.

San Diego, CA

162 employees

www.gossamerbio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Faheem Hasnain

View full financials

Third-Party DCF Estimate (FMP)	$112.57
Price Gap vs Third-Party Estimate	+956.97%

7D Total Return	-7.55%
30D Total Return	-24.04%
YTD Total Return	-95.71%
1Y Total Return	-94.82%
3Y Total Return	-80.30%
5Y Total Return	-98.91%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-95.71%
2025	+242.68%
2024	-0.86%
2023	-57.95%
2022	-80.81%
2021	+16.96%
2020

CAGR TTM	-94.75%
CAGR 3Y	-41.81%
CAGR 5Y	-59.51%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

GOSS Valuation Metrics

GOSS Stock Price Metrics

GOSS Dividend Metrics

GOSS Growth Rate Metrics

GOSS Discounted Cash Flow Metrics

GOSS Returns By Period

GOSS Yearly Returns

GOSS Average Annual Returns By Period (CAGR)

GOSS Revenue Metrics

GOSS PE Ratio Metrics

GOSS PS Ratio Metrics

GOSS PB Ratio Metrics

GOSS Price to Free Cash Flow Ratio Metrics

GOSS Debt to Equity Ratio Metrics

GOSS PEG Ratio Metrics

GOSS FCF Yield

GOSS Earnings Yield

GOSS EBITDA Yield

GOSS OCF Yield

GOSS EV/EBIT Ratio Metrics

GOSS EV/EBITDA Ratio Metrics

GOSS EV/Assets Ratio Metrics

GOSS EV/Sales Ratio Metrics

GOSS Current Ratio Metrics

GOSS Quick Ratio Metrics

GOSS ROIC Metrics

GOSS Return on Assets Metrics

GOSS Return on Equity Metrics

GOSS Net Profit Margin Metrics

GOSS Gross Profit Margin Metrics

GOSS Tax Rate Metrics

PS Ratio	0.82
PS Ratio Avg TTM	6.22
PS Ratio Avg 3Y	5.05
Current VS TTM Avg	-86.81%
Current VS 3Y Avg	-83.77%
Current VS 5Y Avg	-83.77%

PB Ratio	8.07
PB Ratio Avg TTM	5.15
PB Ratio Avg 3Y	5.12
Current VS TTM Avg	+56.67%
Current VS 3Y Avg	+57.51%
Current VS 5Y Avg	+124.68%

PFCF Ratio	53.93
PFCF Ratio Avg TTM	35.77
PFCF Ratio Avg 3Y	35.77
Current VS TTM Avg	+50.77%
Current VS 3Y Avg	+50.77%
Current VS 5Y Avg	+50.77%

Debt/Equity Ratio	(0.42)
Debt/Equity Ratio Avg TTM	(2.04)
Debt/Equity Ratio Avg 3Y	1.06
Current VS TTM Avg	+79.59%
Current VS 3Y Avg	-139.38%
Current VS 5Y Avg	-137.27%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	1.85%
FCF Yield Avg TTM	2.91%
FCF Yield Avg 3Y	2.91%
Current VS TTM Avg	-36.38%
Current VS 3Y Avg	-36.38%
Current VS 5Y Avg	-36.38%

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.54
Ev/Assets Ratio Avg TTM	2.24
Ev/Assets Ratio Avg 3Y	1.24
Current VS TTM Avg	-75.91%
Current VS 3Y Avg	-56.56%
Current VS 5Y Avg	-64.57%

Ev/Sales Ratio	0.78
Ev/Sales Ratio Avg TTM	9.45
Ev/Sales Ratio Avg 3Y	7.55
Current VS TTM Avg	-91.75%
Current VS 3Y Avg	-89.68%
Current VS 5Y Avg	-89.68%

Current Ratio	0.53
Current Ratio Avg TTM	2.61
Current Ratio Avg 3Y	5.08
Current VS TTM Avg	-79.79%
Current VS 3Y Avg	-89.61%
Current VS 5Y Avg	-90.79%

Quick Ratio	0.53
Quick Ratio Avg TTM	2.61
Quick Ratio Avg 3Y	5.08
Current VS TTM Avg	-79.79%
Current VS 3Y Avg	-89.61%
Current VS 5Y Avg	-90.79%

ROIC	N/A
ROIC Avg 3Y	(73.82%)
ROIC Avg 5Y	(74.09%)
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A

ROA	(162.91%)
ROA Avg TTM	(16.12%)
ROA Avg 3Y	(18.31%)
Current VS TTM Avg	-910.38%
Current VS 3Y Avg	-789.78%
Current VS 5Y Avg	-782.03%

ROE	N/A
ROE Avg TTM	(271.10%)
ROE Avg 3Y	(323.52%)
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Net Profit Margin	(235.00%)
Net Profit Margin Avg TTM	(226.09%)
Net Profit Margin Avg 3Y	(163.59%)
Current VS TTM Avg	-3.94%
Current VS 3Y Avg	-43.65%
Current VS 5Y Avg	-132.05%

Gross Profit Margin	99.56%
Gross Pft Margin Avg TTM	99.73%
Gross Pft Margin Avg 3Y	69.13%
Current VS TTM Avg	-0.17%
Current VS 3Y Avg	+44.03%
Current VS 5Y Avg	+132.66%

Tax Rate	0.00%
Tax Rate Avg 3Y	4.13%
Tax Rate Avg 5Y	4.13%
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	-100.00%
Current VS 10Y Avg	-100.00%